<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC6982783/results/search/disease/results.xml">
  <result pre="antiviral lignans—podophyllotoxin and bicyclol, which are used to treat venereal" exact="warts" post="and chronic hepatitis B (CHB) in clinical, serve as"/>
  <result pre="and bicyclol, which are used to treat venereal warts and" exact="chronic hepatitis" post="B (CHB) in clinical, serve as examples of using"/>
  <result pre="bicyclol, which are used to treat venereal warts and chronic" exact="hepatitis" post="B (CHB) in clinical, serve as examples of using"/>
  <result pre="related dengue virus (DENV); MOA showed that it inhibits DENV" exact="infection" post="by targeting genome replication and viral assembly [22]. Moreover,"/>
  <result pre="that it inhibits DENV infection by targeting genome replication and" exact="viral" post="assembly [22]. Moreover, NDGA showed the effect against hepatitis"/>
  <result pre="and viral assembly [22]. Moreover, NDGA showed the effect against" exact="hepatitis" post="C virus (HCV), West Nile Virus (WNV), and Zika"/>
  <result pre="simultaneously with NDGA; the results showed both compounds inhibited the" exact="infection" post="of WNV and ZIKA, with good and similar IC50"/>
  <result pre="and similar IC50 values, and MOA was likely by impairing" exact="viral" post="replication [24]. Meanwhile, Pollara showed that TMP inhibits poxvirus"/>
  <result pre="were some reports regarding the antiviral activity of TMP against" exact="herpes" post="simplex virus (HSV) and human immunodeficiency virus (HIV) [28,29]."/>
  <result pre="activity of TMP against herpes simplex virus (HSV) and human" exact="immunodeficiency" post="virus (HIV) [28,29]. Moreover, it was made into vaginal"/>
  <result pre="vacuolar ATPase (V-ATPase) inhibitor [50]. For example, it blocked ZIKV" exact="infection" post="in HT1080 cells with an IC50 of ~0.06 μM"/>
  <result pre="IC50 of ~0.06 μM [51]; it also altered the cellular" exact="susceptibility to" post="IAV through the inhibition of endosomal acidification, thus interfering"/>
  <result pre="showed that DGP inhibits ZIKV fusion with cellular membranes and" exact="infection" post="by preventing the acidification of endosomal/lysosomal compartments in the"/>
  <result pre="was initially found in Dysosmae Verspiellis Rhixoma Et Radix or" exact="American" post="mandrake or mayapple (all belong to family Berberidaceae) [3]."/>
  <result pre="first cited in 1942 as a topical treatment for venereal" exact="warts" post="(Condyloma acuminatum), which is an ailment that is caused"/>
  <result pre="that podophyllotoxin 0.5% solution has a beneficial effect on anoenital" exact="warts" post="and it is effective and safe for untreated anogenital"/>
  <result pre="warts and it is effective and safe for untreated anogenital" exact="warts" post="in immunocompetent individuals [58]. 2.1.4. Substituted Tetrahydrofurans Substituted tetrahydrofurans"/>
  <result pre="IAV-induced pro-inflammatory response [62]; the underlying defense mechanism against IAV" exact="infection" post="is from pharmacological actions on the immune system, signal"/>
  <result pre="Antiviral studies show that phillygenin has good protective effects against" exact="infections" post="that are caused by IAV; it could reduce inflammation"/>
  <result pre="a traditional Chinese medicine for treating hepatitis, myocardial disorders, and" exact="hyperlipidemia" post="and neurodegenerative diseases in the countries of East Asia"/>
  <result pre="the Chinese Food and Drug Administration (CFDA) for the treatment" exact="of liver" post="injury in 2004 [76]. Bicyclol(4,4′-dimethoxy-5,6,5′,6′-bis(methylenedioxy)-2-hydroxymethyl-2′-methoxycarbonyl biphenyl) is an analog"/>
  <result pre="that bicyclol significantly inhibited HCV replication in vitro and in" exact="hepatitis" post="C patients [79]. Mechanistic studies suggest that anti-hepatitis activity"/>
  <result pre="[79]. Bicyclol is now used to treat the patients with" exact="chronic hepatitis" post="B in China [80]. Rubrifloralignan A was isolated from"/>
  <result pre="Bicyclol is now used to treat the patients with chronic" exact="hepatitis" post="B in China [80]. Rubrifloralignan A was isolated from"/>
  <result pre="derivatives were shown to be a nonnucleoside inhibitor of HIV" exact="type 1" post="reverse transcriptase [83]. 2.2. Neolignans Neolignans are a class"/>
  <result pre="Antiviral Development Lignans are traditionally defined as a class of" exact="secondary" post="metabolites that are derived from the oxidative dimerization of"/>
  <result pre="public health concern with increased global travel and emergence of" exact="viral" post="resistance to the clinical antiviral drugs. There is an"/>
  <result pre="an urgent need to develop novel antiviral drugs targeting different" exact="viral" post="and host proteins. Lignans, as discussed in this review,"/>
  <result pre="bicyclol, which show high potency in the treatment of venereal" exact="warts" post="and chronic hepatitis B, respectively—serve as good examples of"/>
  <result pre="show high potency in the treatment of venereal warts and" exact="chronic hepatitis" post="B, respectively—serve as good examples of developing lignans for"/>
  <result pre="high potency in the treatment of venereal warts and chronic" exact="hepatitis" post="B, respectively—serve as good examples of developing lignans for"/>
  <result pre="Staphylococcus aureusJ. Nat. Prod.20016458859110.1021/np000307b11374949 9.HiranoT.WakasugiA.OoharaM.OkaK.SashidaY.Suppression of mitogen-induced proliferation of human" exact="peripheral" post="blood lymphocytes by plant lignansPlanta Med.199157410.1055/s-2006-960110 10.IwasakiT.KondoK.KurodaT.MoritaniY.YamagataS.SugiuraM.KikkawaH.KaminumaO.IkezawaK.Novel selective PDE"/>
  <result pre="12.HuangR.L.HuangY.L.OuJ.C.ChenC.C.HsuF.L.ChangC.Screening of 25 compounds isolated from Phyllanthus species for anti-human" exact="hepatitis" post="B virus in vitroPhytother Res.20031744945310.1002/ptr.116712748977 13.PilkingtonL.I.Lignans: A Chemometric AnalysisMolecules201823166610.3390/molecules2307166629987225"/>
  <result pre="in vivo and attenuates renal damage and apoptosis in the" exact="ischemia" post="and reperfusion modelPhytomedicine20132077577910.1016/j.phymed.2013.03.02023643094 19.TongW.DingX.AdrianT.The mechanisms of lipoxygenase inhibitor-induced apoptosis"/>
  <result pre="reperfusion modelPhytomedicine20132077577910.1016/j.phymed.2013.03.02023643094 19.TongW.DingX.AdrianT.The mechanisms of lipoxygenase inhibitor-induced apoptosis in human" exact="breast cancer" post="cellsBiochem. Biophys. Res. Commun.200229694294810.1016/S0006-291X(02)02014-412200139 20.ManzaneroS.SantroT.ArumugamT.V.Neuronal oxidative stress in acute"/>
  <result pre="modelPhytomedicine20132077577910.1016/j.phymed.2013.03.02023643094 19.TongW.DingX.AdrianT.The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast" exact="cancer" post="cellsBiochem. Biophys. Res. Commun.200229694294810.1016/S0006-291X(02)02014-412200139 20.ManzaneroS.SantroT.ArumugamT.V.Neuronal oxidative stress in acute"/>
  <result pre="breast cancer cellsBiochem. Biophys. Res. Commun.200229694294810.1016/S0006-291X(02)02014-412200139 20.ManzaneroS.SantroT.ArumugamT.V.Neuronal oxidative stress in" exact="acute" post="ischemic stroke: Sources and contribution to cell injuryNeurochem. Int.20136271271810.1016/j.neuint.2012.11.00923201332"/>
  <result pre="lungsFree Radic Res.20064052353310.1080/1071576050041936516551579 22.SotoA.R.BautistaC.P.SyedG.H.SiddiquiA.Del AngelR.M.Nordihydroguaiaretic acid (NDGA) inhibits replication and" exact="viral" post="morphogenesis of dengue virusAntivir. Res.201410913214010.1016/j.antiviral.2014.07.00225017471 23.SyedG.H.SiddiquiA.Effects of hypolipidemic agent"/>
  <result pre="23.SyedG.H.SiddiquiA.Effects of hypolipidemic agent nordihydroguaiaretic acid on lipid droplets and" exact="hepatitis" post="C virusHepatology2011541936194610.1002/hep.2461921858850 24.Merino-RamosT.de OyaN.J.SaizJ.-C.Martín-AcebesM.A.Antiviral Activity of Nordihydroguaiaretic Acid and"/>
  <result pre="VirusAntimicrob. Agents Chemother.20176110.1128/AAC.00376-17 25.WangS.LeT.Q.KuriharaN.ChidaJ.CisseY.YanoM.KidoH.Influenza virus-cytokine-protease cycle in the pathogenesis of" exact="vascular" post="hyperpermeability in severe influenzaJ. Infect. Dis.2010202991100110.1086/65604420731583 26.OyegunwaA.O.SikesM.L.WilsonJ.R.ScholleF.LasterS.M.Tetra-O-methyl nordihydroguaiaretic acid"/>
  <result pre="Mutation Insensitive Transcription Inhibitor Tetra-O-methyl-NDGAJ. Med. Chem.1998413001300710.1021/jm980182w9685239 29.GnabreJ.N.BradyJ.N.ClantonD.J.ItoY.DittmerJ.BatesR.B.HuangR.C.Inhibition of human" exact="immunodeficiency" post="virus type 1 transcription and replication by DNA sequence-selective"/>
  <result pre="Transcription Inhibitor Tetra-O-methyl-NDGAJ. Med. Chem.1998413001300710.1021/jm980182w9685239 29.GnabreJ.N.BradyJ.N.ClantonD.J.ItoY.DittmerJ.BatesR.B.HuangR.C.Inhibition of human immunodeficiency virus" exact="type 1" post="transcription and replication by DNA sequence-selective plant lignansProc. Natl."/>
  <result pre="C19904512151221 36.EichE.PertzH.KalogaM.SchulzJ.PertzH.EichE.PommierY.(−)-Arctigenin as a Lead Structure for Inhibitors of Human" exact="Immunodeficiency" post="Virus Type-1 IntegraseJ. Med. Chem.199639869510.1021/jm950387u8568830 37.KuoY.C.KuoY.H.LinY.L.TsaiW.J.Yatein from Chamaecyparis obtusa"/>
  <result pre="Virus Type-1 IntegraseJ. Med. Chem.199639869510.1021/jm950387u8568830 37.KuoY.C.KuoY.H.LinY.L.TsaiW.J.Yatein from Chamaecyparis obtusa suppresses" exact="herpes" post="simplex virus type 1 replication in HeLa cells by"/>
  <result pre="Med. Chem.199639869510.1021/jm950387u8568830 37.KuoY.C.KuoY.H.LinY.L.TsaiW.J.Yatein from Chamaecyparis obtusa suppresses herpes simplex virus" exact="type 1" post="replication in HeLa cells by interruption the immediate-early gene"/>
  <result pre="al.Specific Plant Terpenoids and Lignoids Possess Potent Antiviral Activities against" exact="Severe" post="Acute Respiratory Syndrome CoronavirusJ. Med. Chem.2007504087409510.1021/jm070295s17663539 47.RozáliaP.AbrantesM.SerlyJ.DuarteN.MolnarJ.FerreiraM.-J.U.Antitumor-promoting Activity of"/>
  <result pre="Plant Terpenoids and Lignoids Possess Potent Antiviral Activities against Severe" exact="Acute" post="Respiratory Syndrome CoronavirusJ. Med. Chem.2007504087409510.1021/jm070295s17663539 47.RozáliaP.AbrantesM.SerlyJ.DuarteN.MolnarJ.FerreiraM.-J.U.Antitumor-promoting Activity of Lignans:"/>
  <result pre="Terpenoids and Lignoids Possess Potent Antiviral Activities against Severe Acute" exact="Respiratory" post="Syndrome CoronavirusJ. Med. Chem.2007504087409510.1021/jm070295s17663539 47.RozáliaP.AbrantesM.SerlyJ.DuarteN.MolnarJ.FerreiraM.-J.U.Antitumor-promoting Activity of Lignans: Inhibition"/>
  <result pre="and Lignoids Possess Potent Antiviral Activities against Severe Acute Respiratory" exact="Syndrome" post="CoronavirusJ. Med. Chem.2007504087409510.1021/jm070295s17663539 47.RozáliaP.AbrantesM.SerlyJ.DuarteN.MolnarJ.FerreiraM.-J.U.Antitumor-promoting Activity of Lignans: Inhibition of"/>
  <result pre="Medicinal Plant Justicia gendarussaJ. Nat. Prod.2017801798180710.1021/acs.jnatprod.7b0000428613071 56.ZalesakF.BonD.J.D.PospisilJ.Lignans and Neolignans: Plant" exact="secondary" post="metabolites as a reservoir of biologically active substancesPharm. Res.201914610428410.1016/j.phrs.2019.104284"/>
  <result pre="pro-inflammatory responseJ. Ethnopharmacol.201517437938610.1016/j.jep.2015.08.03726320688 63.ZhouB.LiJ.LiangX.YangZ.JiangZ.Transcriptome profiling of influenza A virus-infected lung" exact="epithelial" post="(A549) cells with lariciresinol-4-beta-D-glucopyranoside treatmentPLoS ONE201712e017305828273165 64.LiuZ.L.LiuY.Q.ZhaoL.XuJ.TianX.The phenylpropanoids of"/>
  <result pre="activity of Isatis indigotica root-derived clemastanin B against human and" exact="avian influenza" post="A and B viruses in vitroInt. J. Mol. Med.20133186787310.3892/ijmm.2013.127423403777"/>
  <result pre="Mol. Med.20133186787310.3892/ijmm.2013.127423403777 67.FanhchaksaiK.KodchakornK.PothacharoenP.KongtawelertP.Effect of sesamin against cytokine production from influenza" exact="type A" post="H1N1-induced peripheral blood mononuclear cells: Computational and experimental studiesVitr."/>
  <result pre="of sesamin against cytokine production from influenza type A H1N1-induced" exact="peripheral" post="blood mononuclear cells: Computational and experimental studiesVitr. Cell Dev."/>
  <result pre="with chemometricsPhytomed. Int. J. Phytother. Phytopharm.201320910.1016/j.phymed.2013.05.00123880331 74.YuJ.-S.WuY.-H.TsengC.-K.LinC.-K.HsuY.-C.ChenY.-H.LeeJ.-C.Schisandrin A inhibits dengue" exact="viral" post="replication via upregulating antiviral interferon responses through STAT signaling"/>
  <result pre="to non-nucleoside inhibitorsJ. Microbiol.201553610.1007/s12275-015-4652-025557476 76.LiuG.Bicyclol: A Novel Drug for Treating" exact="Chronic" post="Viral Hepatitis B and CMed. Chem.20095294310.2174/15734060978704931619149648 77.ZhangT.New drugs derived"/>
  <result pre="non-nucleoside inhibitorsJ. Microbiol.201553610.1007/s12275-015-4652-025557476 76.LiuG.Bicyclol: A Novel Drug for Treating Chronic" exact="Viral" post="Hepatitis B and CMed. Chem.20095294310.2174/15734060978704931619149648 77.ZhangT.New drugs derived from"/>
  <result pre="inhibitorsJ. Microbiol.201553610.1007/s12275-015-4652-025557476 76.LiuG.Bicyclol: A Novel Drug for Treating Chronic Viral" exact="Hepatitis" post="B and CMed. Chem.20095294310.2174/15734060978704931619149648 77.ZhangT.New drugs derived from medicinal"/>
  <result pre="bicyclol therapy for patients with genotype B and C of" exact="hepatitis" post="B virusChin. J. Exp. Clin. Virol.2007213 79.HuangM.-H.LiH.XueR.LiJ.WangL.ChengJ.WuZ.LiW.ChenJ.LvX.et al.Up-regulation of"/>
  <result pre="of glycolipid transfer protein by bicyclol causes spontaneous restriction of" exact="hepatitis" post="C virus replicationActa Pharm. Sin. B2019976978110.1016/j.apsb.2019.01.01331384537 80.ZhouY.ChaiX.Protective effect of"/>
  <result pre="virus replicationActa Pharm. Sin. B2019976978110.1016/j.apsb.2019.01.01331384537 80.ZhouY.ChaiX.Protective effect of bicyclol against" exact="pulmonary" post="fibrosis via regulation of microRNA5 in ratsJ. Cell. Biochem.201912165166010.1002/jcb.2931031407409"/>
  <result pre="and Related Anti-HIV Compounds from Schisandra rubrifloraJ. Nat. Prod.2006691697170110.1021/np060239e17190445 83.FujihashiT.HaraH.SakataT.MoriK.HiguchiH.TanakaA.KajiH.KajiA.Anti-human" exact="immunodeficiency" post="virus (HIV) activities of halogenated gomisin J derivatives, new"/>
  <result pre="of halogenated gomisin J derivatives, new nonnucleoside inhibitors of HIV" exact="type 1" post="reverse transcriptaseAntimicrob. Agents Chemother.1995392000200710.1128/AAC.39.9.20008540706 84.FedericoA.DallioM.LoguercioC.Silymarin/Silybin and Chronic Liver Disease:"/>
  <result pre="of HIV type 1 reverse transcriptaseAntimicrob. Agents Chemother.1995392000200710.1128/AAC.39.9.20008540706 84.FedericoA.DallioM.LoguercioC.Silymarin/Silybin and" exact="Chronic" post="Liver Disease: A Marriage of Many YearsMolecules20172219110.3390/molecules2202019128125040 85.StraderD.B.BaconB.R.LindsayK.L.La BrecqueD.R.MorganT.WrightE.C.SeeffffL.B.Use"/>
  <result pre="Silymarin and DerivativesMolecules201924155210.3390/molecules24081552 87.WagonerJ.NegashA.KaneO.J.MartinezL.E.NahmiasY.BourneN.OwenD.M.GroveJ.BrimacombeC.McKeatingJ.A.et al.Multiple effects of silymarin on the" exact="hepatitis" post="C virus lifecycleHepatology2010511912192110.1002/hep.2358720512985 88.DebRoyS.HiragaN.ImamuraM.HayesC.N.AkamatsuS.CaniniL.PerelsonA.S.PohlR.T.PersianiS.UprichardS.L.Hepatitis C virus dynamics and cellular"/>
  <result pre="uPA-SCID chimeric mice with humanized livers during intravenous silibinin monotherapyJ." exact="Viral" post="Hepat.20162370871710.1111/jvh.1255127272497 89.SongJ.H.ChoiH.J.Silymarin efficacy against influenza a virus replicationPhytomedicine20111883283510.1016/j.phymed.2011.01.02621377857 90.LiJ.MengA.-P.GuanX.-L.LiJ.WuQ.DengS.-P.SuX.-J.YangR.-Y.Anti-hepatitis"/>
  <result pre="for the improvement of the abnormal liver function of CHB" exact="hepatitis" post="in China. Bicyclol as a novel substitute for DDB"/>
  <result pre="protection against liver injury and was also showed to inhibit" exact="hepatitis" post="virus replication in vitro and in vivo. Figure 10"/>
  <result pre="No data No data In Vitro targets genome replication and" exact="viral" post="assembly [22,23,24,25] HCV 30 70 in Huh7 NDGA-mediated alterations"/>
  <result pre="Leaves (resin) WNV/ZIKV 9.3/5.7 1071.0 in Vero In Vitro impaires" exact="viral" post="replication [24,26,27,28,29,30] poxvirus No data No data In Vitro"/>
  <result pre="the binding of the host cell transcription factor, Sp1, to" exact="viral" post="promoters. HIV 25 No data In Vitro HPV In"/>
  <result pre="data In Vitro HPV In Clinical selectively interferes with HPV" exact="viral" post="genes E6/E7 with Sp1dependent promoters, and induces apoptosis by"/>
  <result pre="Aryltetralins Dysosmae Verspiellis &amp;amp; Podophyllum peltatum (Berberidaceae) Roots and stems" exact="Papilloma" post="virus Launched in China waiting for the deeper research"/>
  <result pre="Clemastanin B IAV 0.087–0.72 mg/mL 6.2–7.5 mg/mL In Vitro targets" exact="viral" post="endocytosis, uncoating or RNP export from the nucleus [66]"/>
  <result pre="IAV No data No data In Vitro inhibition of late" exact="viral" post="RNA synthesis Dimer of strebluslignanols (7′R,8′S,7″R,8″S)-erythro-strebluslignanolG Streblus asper (Moraceae)"/>
 </snippets>
</snippetsTree>
